Coconut stopped being a major food allergen in the United States in January 2025. FDA’s current allergen guidance names twelve tree nuts that carry labelling duties, and coconut is not one of them. In the EU it was never on the list. For a buyer shipping one desiccated coconut lot into both markets, coconut allergen labelling is closer to aligned than at any point since 2004.
The ingredient still has to be named. Every market covered below requires coconut in the ingredient list under ordinary labelling rules. What moved is the allergen box: the “Contains” statement in the US, the emphasised text in the EU.
The live risk on a coconut line sits elsewhere. Desiccated coconut, coconut flour and coconut milk powder are often dried, milled or packed on equipment that also runs cashew, almond or peanut. That is real tree nut protein, declarable in every market on this page.
Is coconut a major food allergen in the United States?
No. FDA’s guidance on food allergen labelling, Edition 5, issued January 2025, carries a table of the tree nuts FDA treats as major food allergens. It runs to twelve entries: almond, black walnut, Brazil nut, California walnut, cashew, filbert/hazelnut, heartnut, macadamia, pecan, pine nut, pistachio and walnut. The word coconut appears nowhere in the document.
The operative sentence, at Q&A C.8:
“Only the tree nuts listed in Table 1 are considered major food allergens … they should not be included in the ‘Contains’ statement even if they are used as ingredients … Tree nuts used as ingredients, but not listed in Table 1, would still be required to be listed by common or usual name in the ingredient list.”
No rule change was needed. FALCPA defines a major food allergen at 21 U.S.C. 321(qq) and offers only three examples of tree nuts, “almonds, pecans, or walnuts”. The working roster has always been FDA interpretation, which is why a guidance revision could move it.
Compare the other direction. Adding sesame as the ninth major allergen took an Act of Congress, the FASTER Act of 2021, applying to food introduced into commerce on or after 1 January 2023.
Two cautions for compliance staff. First, 21 CFR 170.3(n)(32) still groups coconut with nuts, but that paragraph is a food-category list used for additive purposes, not an allergen list. Second, enforcement text lags the guidance: FDA recall entries H-1274-2026 and H-1275-2026, both dated 2 September 2026, describe “undeclared wheat, soy, milk, eggs and tree nut (coconut)” on imported product carrying foreign-language packaging.
FDA published no coconut-specific reasoning. Prevalence gives the context: a 2023 population survey of 78,851 people in Annals of Allergy, Asthma & Immunology put convincing coconut allergy at 0.39%, roughly one person in 260.
Does the EU require coconut to be declared as an allergen?
No. Annex II to Regulation (EU) No 1169/2011 lists fourteen substances causing allergies or intolerances. Entry 8 is specific:
“Nuts, namely: almonds (Amygdalus communis L.), hazelnuts (Corylus avellana), walnuts (Juglans regia), cashews (Anacardium occidentale), pecan nuts, Brazil nuts (Bertholletia excelsa), pistachio nuts (Pistacia vera), macadamia or Queensland nuts (Macadamia ternifolia), and products thereof”
Eight nuts, pinned to their botanical names. Coconut is absent, and so are chestnut and pine nut. Article 21 then requires a listed allergen to be emphasised in the ingredient list “through a typeset that clearly distinguishes it from the rest of the list of ingredients, for example by means of the font, style or background colour”.
The UK Food Standards Agency states the position plainly in its allergen labelling technical guidance: other foods “which are not nuts (even though they are called nuts, such as chestnuts, pine nuts and coconut), are not named in the rules”.
Britain kept the same Annex II after Brexit. UK divergence is about scope: Natasha’s Law extended emphasised-allergen labelling to prepacked for direct sale food from 1 October 2021.
Where does that leave Canada, Australia and Codex?
In the same place. Canada’s Food and Drug Regulations name nine tree nuts, none of them coconut. The CFIA goes further and allows a positive claim: “Products containing coconut can declare ‘does not contain tree nuts or peanuts’.”
Australia and New Zealand closed the Plain English Allergen Labelling transition on 25 February 2024, with the stock-in-trade window ending 26 February 2026. PEAL requires each of nine tree nuts by its mandated name, so a generic “tree nuts” declaration no longer satisfies the Code. Coconut is not on the list.
At Codex level, the FAO/WHO expert committee recommended six tree nuts as global priority allergens: almond, cashew, hazelnut, pecan, pistachio and walnut. Brazil nut, macadamia and pine nut were left to national discretion. Coconut sits in neither group.
| Market | Instrument | Tree nuts named | Coconut an allergen? |
|---|---|---|---|
| United States | FALCPA; FDA allergen guidance Ed. 5 (Jan 2025) | 12 | No. Ingredient list only |
| European Union | Reg (EU) 1169/2011, Annex II entry 8 | 8 | No. Ingredient list only |
| United Kingdom | Assimilated Reg 1169/2011, same Annex II | 8 | No |
| Canada | Food and Drug Regulations B.01.010.1 | 9 | No |
| Australia / NZ | Food Standards Code Std 1.2.3 (PEAL) | 9 | No |
| Codex | FAO/WHO global priority list | 6 | No |
Then why does coconut still complicate a label?
Cross-contact. A coconut ingredient rarely runs on dedicated equipment at origin, and cashew is the usual neighbour in Vietnam and India.
FDA is explicit that a cross-contact allergen must not be put in the ingredient list or the “Contains” statement. That pushes the exposure into precautionary labelling, which moved in July 2026. Codex adopted a “may contain” annex to CXS 1-1985 at its 49th session, held 6 to 10 July 2026. The test it sets is that such statements “should be used only after food businesses have implemented appropriate allergen management measures and conducted a scientific risk assessment demonstrating that a residual risk from unintended allergen presence remains”.
The EU has not harmonised precautionary labelling. The Commission’s February 2026 allergen factsheet still frames it as something businesses “may use”, grounded in a risk assessment. A blanket “may contain tree nuts” across a coconut range stays cheap to print and is getting harder to defend at audit.
What should the contract and the supplier file carry?
Clause 2.5.6 of FSSC 22000 version 6 sets the shape of a compliant allergen management plan: a list of every allergen handled on site, a risk assessment of all cross-contamination sources, control measures, risk-based verification testing where different allergen profiles share a line, precautionary labels only where residual risk survives those controls, training, and annual review.
Clause 2.5.2(a) decides whose rules apply. Finished product must be labelled to the statutory requirements “in the country of intended sale”. A mill in Sri Lanka or the Philippines is not labelling to its own market’s rules. It labels to yours, which is why one lot split across four destinations needs four label reviews.
One check before quoting clause numbers at a supplier: audits still run against v6 of April 2023, and FSSC published version 7 in May 2026 with a transition running into 2027.
What the desk asks for on a coconut program:
- allergen statement per SKU, covering allergens in the product and allergens handled on site
- cross-contact risk assessment naming shared dryers, mills, packing lines, storage and transport
- verification records, surface swab or product testing, where tree nut lines share the facility
- written justification for any precautionary statement, dated and signed
- destination-market label conformity confirmed market by market
- the allergen clause written into the ingredient specification rather than left to the COA
What this means for buyers
- Procurement, CPG manufacturer (Persona A): pull your US artwork. A printed “Contains: tree nuts (coconut)” is now wrong under FDA’s guidance, and it invites a question at audit.
- Importer / distributor (Persona B): the four-market label matrix is a per-SKU document, not a supplier promise. Hold it yourself. US importers carry the verification duty anyway under FSVP.
- Brand owner scaling up (Persona C): ask which lines your desiccated coconut runs on before you ask about price. Cashew on the same dryer costs more than two cents a kilo to manage.
- All buyers: coconut allergen labelling is now the settled part of the file. Treat any “may contain tree nuts” statement as a claim that needs a risk assessment behind it, and ask to see it.
FAQ
Is coconut a tree nut? Botanically it is a drupe. For labelling, FDA removed it from its tree nut allergen table in January 2025, and the EU, UK, Canada, Australia and New Zealand have never listed it. It is declared as an ordinary ingredient.
Do I still write coconut in the ingredient list? Yes, in every market covered here. Ordinary ingredient labelling rules apply, using the common or usual name. Only the allergen declaration changed.
Can a coconut product be labelled “tree nut free”? In Canada, CFIA permits “does not contain tree nuts or peanuts” on a coconut product. Elsewhere, treat it as a claim needing cross-contact evidence from the manufacturing site before it goes on artwork.
Does the allergen statement belong in the contract or the COA? The contract, via the ingredient specification. A COA reports one tested lot. The allergen position is a facility matter that has to hold across every shipment.
Running one coconut spec into several markets and unsure the labels agree? Send the desk an RFQ.